References
- 1. Adaszek Ł., Winiarczyk S.: Molecular characterization of Babesia canis canis isolates from naturally infected dogs in Poland. Vet Parasitol 2008, 152, 235-241.
- 2. Adaszek Ł., Winiarczyk S., Skrzypczak M.: The clinical course of babesiosis in 76 dogs infected with protozoa parasites Babesia canis canis. Pol J Vet Sci 2009, 12, 81-87.
- 3. Adaszek Ł., Winiarczyk, S.: In vitro cultivation of Babesia canis canis parasites isolated from dogs in Poland. Parasitol Res 2011, 108, 1303-1307.
- 4. Adaszek Ł., Carbonero-Martinez A., Winiarczyk S.: The factors affecting the distribution of babesiosis in dogs in Poland. Vet Parasitol 2011, 81, 160-165.
- 5. Adaszek Ł., Wernicka-Furmaga R., Winiarczyk S.: Preliminary study on the safety of a new vaccine against canine babesiosis containing soluble parasitic antigen (SPA). Bull Vet Inst Pulawy 2012, 56, 145-148.
- 6. Ahmed J.S.: The role of cytokines in immunity and immunopathogenesis of piroplasmoses. Parasitol Res 2002, 88, 48-50.
- 7. Brown W.C., Logan K.S:. Babesia bovis: bovine helper T cell lines reactive with soluble and membrane antigens of merozoites. Exp Parasitol 1992, 74, 188-199.
- 8. Brown W.C., Ruef B.J., Norimine J., Kegerreis K.A., Suarez C.E., Conley P.G., Stich R.W., Carson K.H., Rice-Ficht A.C.: A novel 20-kilodalton protein conserved in Babesia bovis and B. bigemina stimulates memory CD4(+) T lymphocyte responses in B. bovis-immune cattle. Mol Biochem Parasitol 2001, 118, 97-109.
- 9. Carcy B., Précigout E., Schetters T., Gorenflot A.: Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity. Vet Parasitol 2006, 138, 33-49.
- 10. De Lima V.M., Ikeda F.A., Rossi C.N., Feitosa M.M., Vasconcelos R.O., Nunes C.M., Goto H.:. Diminished CD4+/CD25+ T cell and increased IFN-γ levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis. Vet Immunol Immunopathol 2010, 135, 296-302.
- 11. Eckert J., Deplazes P.: Vaccines against parasitic diseases of domestic animals. Tierarztl Prax 1996, 24, 322-329.
- 12. García T.D., Figueroa M.J., Ramos A.J., Rojas M.C., Cantó A.G., Falcón N.A., Alvarez M.J.: Immune response to Babesia bigemina infection in pregnant cows. Ann NY Acad Sci 2004, 1026, 298-301.
- 13. Laurent N., l’Etoile M.: Process for the culture of Babesia canis. Application to the preparation of antigens and vaccine against pyroplasmosis. Patent No. US 4,777,036. 1988
- 14. Miyamoto T., Taura Y., Une S., Yoshitake M., Nakama S., Watanabe S.: Immunological responses after vaccination pre- and post-surgery in dogs. J Vet Med Sci 1995, 57, 29-32.
- 15. Schetters T.P., Kleuskens J., Scholtes N., Bos H.J.: Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture. Parasite Immunol 1992, 14, 295-305.
- 16. Schetters T.P., Montenegro-James S.: Vaccines against babesiosis using soluble parasite antigens. Parasitol Today 1995, 11, 456-462.
- 17. Schetters T.P., Scholtes N.C., Kleuskens J.A., Bos H.J.: Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis. Parasite Immunol 1996, 18, 1-6.
- 18. Schetters T.P., Kleuskens J.A., Scholtes N.C., Pasman J.W., Goovaerts D.: Vaccination of dogs against Babesiacanis infection. Vet Parasitol 1997, 73, 35-41.
- 19. Schetters T.P., Kleuskens J.A., Scholtes N.C., Gorenflot A., Moubri K., Vermeulen A.N.: Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants. Vet Parasitol 2001, 100, 75-86.
- 20. Schetters T.P., Strydom T., Crafford D., Kleuskens J.A., van de Crommert J., Vermeulen A.N., Strasser A., May B., Teltscher A., Wistrela E., Niedermüller H.: Immune modulation following immunization with polyvalent vaccines in dogs. Vet Immunol Immunopathol 2003, 94, 113-121.
- 21. Schetters T.: Vaccination against canine babesiosis. Trends Parasitol 2005, 21, 179-184.
- 22. Schetters T.P., Kleuskens J., Carcy B., Gorenflot A., Vermeulen A.: Vaccination against large Babesia species from dogs. Parassitologia 2007, 49 Suppl 1, 13-17.
- 23. Schetters T.P., Strydom T., Crafford D., Kleuskens J.A., van de Crommert J., Vermeulen A.N.: Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants. Vet Parasitol 2007, 144, 10-19.
- 24. Schetters T.P., Moubri K., Cooke B.M.: Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review. J S Afr Vet Assoc 2009, 80, 75-78.
- 25. Sibinovic K.H., Sibinovic S., Ristic M., Cox H.W.: Immunogenic properties of babesial serum antigens. J. Parasitol 1967, 53, 1121-1129.
- 26. Strasser A., May B., Teltscher A., Wistrela E., Niedermüller H.: Immune modulation following immunization with polyvalent vaccines in dogs. Vet Immunol Immunopathol 2003, 94, 113-121.
- 27. Zygner W., Wedrychowicz H.: Influence of anaemia on azotaemia in dogs infected with Babesia canis in Poland. Bull Vet Inst Pulawy 2009, 53, 663-668.
- 28. Zygner W., Gójska-Zygner O., Wedrychowicz H.: Abnormalities in serum proteins in the course of babesiosis in dogs. Bull Vet Inst Pulawy 2011, 55, 59-65.